ArticleCancer cell international2020

Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway.

Bin Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.